NEUROLOGICAL BIOMARKERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Biomarker Type
     • Market Snapshot, By Application
     • Market Snapshot, By End User
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Regulatory Scenario
   • Acquisitions and Partnerships Scenario
   • Funding and Investments
   • PEST Analysis
   • Porter’s Analysis

4. Global Neurological Biomarkers Market, By Biomarker Type, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Artificial Tears
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Imaging Biomarkers
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Metabolomics Biomarkers
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Proteomic Biomarkers
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Genomics Biomarkers
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

5. Global Neurological Biomarkers Market, By Application, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Alzheimer’s Disease
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Parkinson’s Disease
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Multiple Sclerosis
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Autism Spectrum Disorders
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Others
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Neurological Biomarkers Market, By End User, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Hospital Laboratories
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Clinical Diagnostic Centers
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Research Organizations
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Others
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Neurological Biomarkers Market, By Region, 2021 – 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Region, 2021–2033
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
       • North Africa
       • Central Africa
       • South Africa

8. Competitive Landscape

   • Company Profiles
     • Thermo Fisher Scientific Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Merck & Co., Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Bio-Rad Laboratories, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • AbbVie Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • QIAGEN N.V.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • F. Hoffmann-La Roche Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Siemens Healthineers AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Myriad RBM
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Quanterix Corporation
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • PerkinElmer Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Fujirebio
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Alzheon, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Diagenic ASA
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Psynova Neurotech Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Banyan Biomarkers, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Cisbio Bioassays
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Athena Diagnostics
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Immuno-Biological Laboratories Co., Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies

9. Analyst Recommendations

   • Wheel of Fortune
   • Analyst View
   • Coherent Opportunity Map

10. Section

    • References
    • Research Methodology
    • About Us and Sales Contact